Sucampo Pharmaceuticals Inc Sets New 1-Year High at $10.90 (SCMP)
Sucampo Pharmaceuticals (NASDAQ:SCMP) set a new 52-week high during trading hours on Monday, AR Network reports. The company traded as high as $10.90 and last traded at $10.39, with a volume of 706,116 shares. The stock had previously closed at $9.31.
A number of research firms have recently commented on SCMP. Analysts at Cantor Fitzgerald cut their price target on shares of Sucampo Pharmaceuticals from $11.00 to $10.00 in a research note to investors on Thursday, November 7th. They now have a “buy” rating on the stock. Analysts at Zacks upgraded shares of Sucampo Pharmaceuticals from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, November 6th. They now have a $7.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $9.20.
Sucampo Pharmaceuticals has a 52 week low of $4.55 and a 52 week high of $10.48. The stock’s 50-day moving average is $8.27 and its 200-day moving average is $6.81. The company has a market cap of $436.2 million and a P/E ratio of 21.96.
Sucampo Pharmaceuticals, Inc is a pharmaceutical Company. The Company is focused on the discovery, development and commercialization of drugs based on prostones.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.